BRAF and ganglioglioma: Overall, in LGG, we detected the mutation in 12.6% of the cases; however this proportion rises to 50% when only considering gangliogliomas, a proportion in accordance to that described by previous studies which found the BRAF V600E mutation in between 20–60% of cases [9, 26–30].